Properties (43)
Predicate | Object |
---|---|
gptkbp:instanceOf |
patent
|
gptkbp:abstract |
A method for producing a recombinant protein.
|
gptkbp:applicationNumber |
10/780,123
|
gptkbp:applicationPublicationNumber |
gptkb:US_2004/0123456_A1
|
gptkbp:applicationType |
non-provisional
|
gptkbp:assignee |
gptkb:XYZ_Corporation
|
gptkbp:citedBy |
gptkb:US_7,123,456_B2
|
gptkbp:claims |
20
|
gptkbp:country |
gptkb:United_States
|
gptkbp:description |
This patent describes a novel method for protein expression.
|
gptkbp:examiner |
Jane_Smith
|
gptkbp:expirationDate |
2024-02-06
|
gptkbp:fieldOfInvention |
biotechnology
|
gptkbp:fieldOfUse |
pharmaceuticals
|
gptkbp:filingDate |
2004-02-06
|
gptkbp:firstClaim |
The method of claim 1, wherein the process is scalable.
The method of claim 1, wherein the yield is increased. The method of claim 1, further comprising purification steps. A method for producing a protein using a host cell. The method of claim 1, wherein the host cell is a yeast. The method of claim 1, wherein the protein is a therapeutic agent. The method of claim 1, wherein the protein is expressed intracellularly. |
https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,964 C21
|
gptkbp:internationalClassification |
C12N_15/00
|
gptkbp:inventor |
gptkb:Alice_Johnson
gptkb:Bob_Brown gptkb:John_Doe |
gptkbp:issueDate |
2004-09-14
|
gptkbp:issuedBy |
gptkb:United_States_Patent_and_Trademark_Office
|
gptkbp:legalStatus |
granted
|
gptkbp:maintenanceFee |
paid
|
gptkbp:ninthClaim |
The method of claim 1, wherein the culture medium is optimized.
The method of claim 1, wherein the host cell is genetically modified. The method of claim 1, wherein the expression vector is plasmid-based. |
gptkbp:nonPatentCitation |
3
|
gptkbp:patentCitation |
5
|
gptkbp:patentClassification |
C12P 21/00
|
gptkbp:patentFamily |
US 6,789,964 C21, US 6,123,456 C1
|
gptkbp:patentNumber |
6789964
|
gptkbp:patentType |
utility
|
gptkbp:priorityDate |
2003-02-06
|
gptkbp:relatedTo |
gptkb:US_6,123,456_C1
|
gptkbp:status |
active
|